Logo
  • Login
  • Search
  • Menu
  • Study
  • Research
  • Partner
  • News & Events

  • Study
  • Research
  • Partner
  • News & Events

About

  • UniSA, an overview
  • Giving to UniSA
  • Working at UniSA
  • UniSA International
  • UniSA Online
  • Alumni
  • Campus facilities and maps
  • Events
  • Library
  • Student life
  • Teaching and learning
  • University publications

Login

  • Students
  • Alumni
  • Staff

  • Login

Dr Agnes Vitry

  • Senior Lecturer School of Pharmacy and Medical Sciences
  • City East Campus (P4-22)
  • tel +61 8 830 22392
  • fax +61 8 830 22389
  • email Agnes.Vitry@unisa.edu.au
  • Available for media comment
  • Research Degree Supervisor
  • About me
  • Research
  • External engagement & recognition
  • Teaching & student supervision
  • close

About me

About me

I am a Senior Lecturer at the School of Pharmacy and Health Sciences. My research focuses on three main areas: - medicines policies in Australia and the Western Pacific Region: regulatory approval, funding, pricing, managed entry agreements, affordability, usage, and pharmaceutical promotion; - quality use of medicines in people with comorbidities (elderly people, people living with cancer, residents of nursing homes). - systematic reviews of trial and observational evidence on health outcomes of medicines. In the recent years, I have collaborated with numerous organisations including the Australian Government’s Department of Health (Pharmaceutical Benefits Scheme (PBS) Post-Market Reviews), the Australian Commission on Safety and... Read more

School of Pharmacy and Medical Sciences

With standout facilities and strong industry links, the School prepares students for careers in health and medical science.

Tweets by @UniversitySA
  • Orcid
  • Scopus
  • ResearcherID
  • close

About me

  • back
  • close

About me

I am a Senior Lecturer at the School of Pharmacy and Health Sciences. My research focuses on three main areas: - medicines policies in Australia and the Western Pacific Region: regulatory approval, funding, pricing, managed entry agreements, affordability, usage, and pharmaceutical promotion; - quality use of medicines in people with comorbidities (elderly people, people living with cancer, residents of nursing homes). - systematic reviews of trial and observational evidence on health outcomes of medicines. In the recent years, I have collaborated with numerous organisations including the Australian Government’s Department of Health (Pharmaceutical Benefits Scheme (PBS) Post-Market Reviews), the Australian Commission on Safety and Quality in Health Care, the World Health Organization Western Pacific Region (WPRO) Office, and Health Action International. I am strongly involved in the activities of consumer organisations in particular Cancer Voices SA with the development of a ‘patients as teachers’ academic program and several collaborative research projects.
Close
  • close

About me

  • back
  • close

Professional Associations

Member of the International Society for Pharmacoepidemiology (ISPE).ISPE is an international organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, and therapeutic risk management.,Member of Health Technology Assessment International (HTAi).The mission of HTAi is to support and promote the development, communication, understanding and use of health technology assessment (HTA) around the world, as a scientifically based and multidisciplinary means of informing decision making regarding the introduction of effective innovations and the efficient use of resources in health care.
Close
  • close

About me

  • back
  • close

Experience

Qualifications

  • Doctor of Philosophy University of Paris

  • Masters in Economy and Management of Health Systems University of Paris

  • Bachelor of Pharmacy University of Paris

Close
  • About me
  • Professional associations
  • Experience
  • close

Research

Research themes

  • An age friendly world
  • Cancer
  • Scarce resources

Research focus

  • Public Health and Health Services
  • Clinical Sciences
  • Medical and Health Sciences
  • Pharmacology and Pharmaceutical Sciences
  • Policy and Administration

Highlights

Quality use of medicines,Pharmaco-epidemiology,Medicines policies, pharmaceutical regulations, transparency of medicine agencies,Quality of medicines information for health professionals and consumers, clinical guidelines,Drug promotion, quality use of medicines, conflicts of interests,Assessment of new medicines
  • close

Research

  • back
  • close

Projects

Excludes commercial-in-confidence projects.

  • Evaluation of risks and potential impact of scheduling of ketamine on access on low and middle income countries, World Health Organisation Malaysia, 01/01/2016 - 30/12/2017

Close
  • close

Research

  • back
  • close

Outputs

Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus

Open access indicates that an output is open access.

Chapters

Year Output
2018

Vitry, AI & Shute, R 2018, 'Access to high-cost medicines in Australia', in ZUD Babar (eds), Equitable access to high-cost pharmaceuticals, Academic Press, UK, ch. 11 , pp. 165-181.

2017

Nguyen, TA, Vitry, A & Roughead, EE 2017, 'Pharmaceutical policy in Vietnam', in Z Babar (ed.), Pharmaceutical policy in countries with developing healthcare systems, 1st ed., ADIS - Springer International Publishing, Switzerland, ch. 5, pp. 75-94.

4
2015

Vitry, AI, Thai, L & Roughead, EE 2015, 'Pharmaceutical pricing policies in Australia', in ZUD Babar (ed.), Pharmaceutical prices in the 21st century, Springer, Germany, ch. 1, pp. 1-23.

4 3
2011

Vitry, A & Löfgren, H 2011, 'Health consumer groups and the pharmaceutical industry: is transparency the answer?', in H Lofgren, EE de Leeuw & M Leahy (eds), Democratising health: consumer groups in the policy process, Edward Elgar Publishing Ltd, Cheltenham, UK, ch. 16, pp. 239 - 254.

4 1

Journal Articles

Year Output
2019

Fabbri, A, Swandari, S, Lau, E, Vitry, A & Mintzes, B 2019, 'Pharmaceutical industry funding of health consumer groups in Australia: a cross-sectional analysis', International Journal of Health Services, vol. 49, no. 2, pp. 273-293.

Open access 1 40
2019

Hillen, JB, Vitry, A & Caughey, GE 2019, 'Medication-related quality of care in residential aged care: an Australian experience', International Journal for Quality in Health Care, vol. 31, no. 4, pp. 298-306.

Open access 1 14
2019

Ng, HS, Vitry, A, Koczwara, B, Roder, D & McBride, ML 2019, 'Patterns of comorbidities in women with breast cancer: a Canadian population-based study', Cancer Causes and Control, vol. 30, no. 9, pp. 931-941.

2018

Ng, HS, Koczwara, B, Roder, D & Vitry, A 2018, 'Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014', Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention, vol. 54, pp. 56-62.

Open access
2018

Ng, HS, Koczwara, B, Roder, D & Vitry, A 2018, 'Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study', Prostate Cancer and Prostatic Diseases, vol. 21, pp. 403-410.

Open access 6 5 30
2018

Ng, HS, Koczwara, B, Roder, D, Niyonsenga, T & Vitry, A 2018, 'Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study', Journal of Comorbidity, vol. 8, no. 1, pp. 16-24.

Open access 1
2018

Ng, HS, Koczwara, B, Roder, DM, Niyonsenga, T & Vitry, A I 2018, 'Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis', Medical Journal of Australia, vol. 208, no. 1, pp. 24-28.

3 3
2017

Caughey, GE, Tait, K, Vitry, A I & Shakib, S 2017, 'Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity', Patient Preference and Adherence, vol. 11, pp. 131-140.

Open access 3 2
2017

Grover, P, Babar, ZUD, Oehmen, R & Vitry, A 2017, 'Medicines access programs to cancer medicines in Australia and New Zealand: an exploratory study', Health Policy, vol. 122, no. 3, pp. 243-249.

7
2017

Hillen, J, Vitry, A & Caughey, G 2017, 'Evaluating medication-related quality of care in Australian aged care: a role for collaborative health services', Journal of Pharmacy Practice and Research, vol. 47, no. 1, pp. 63-66.

2017

Hillen, JB, Vitry, A & Caughey, GE 2017, 'Disease burden, comorbidity and geriatric syndromes in the Australian aged care population', Australasian Journal on Ageing, vol. 36, no. 2, pp. E14-E19.

Open access 7 6 3
2017

Ng, HS, Roder, D, Koczwara, B & Vitry, A 2017, 'Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study', Asia Pacific Journal of Clinical Oncology, vol. 14, pp. 181-192.

4 4
2017

Thai, LP, Vitry, AI & Moss, JR 2017, 'Price and utilisation differences for statins between four countries', Expert Review of Pharmacoeconomics and Outcomes Research: Informing Decision-Making in the Delivery of Cost-Effective Healthcare, vol. 18, no. 1, pp. 71-81.

2
2017

Wang, H, Sun, Q, Vitry, A & Nguyen, TA 2017, 'Availability, prices and affordability of selected essential medicines for chronic diseases in 11 countries of the Asia Pacific Region: a secondary analysis', Asia-Pacific Journal of Public Health, 29, no. 4, pp. 268–277.

2 4 5
2016

Caughey, G, Vitry, A, Ramsay, E, Gilbert, A, Shakib, S, Ryan, P, Esterman, A, McDermott, R & Roughead, E 2016, 'Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes', Internal Medicine Journal, vol. 46, no. 12, pp. 1430-1436.

Open access 2 1 29
2016

Hillen, JB, Vitry, A & Caughey, GE 2016, 'Trends in general practitioner services to residents in aged care', Australian Journal of Primary Health, vol. 22, no. 6, pp. 517-522.

4 3 1
2016

Hopkins, AM, Proudman, SM, Vitry, A, Sorich, MJ, Cleland, LG & Wiese, MD 2016, 'Ten years of Publically Funded Biological Disease Modifying Antirheumatic Agents in Australia', Medical Journal of Australia, vol. 204, no. 2, pp.64-68.

7 3 1
2016

Tan, EC, Visvanathan, R, Hilmer, SN, Vitry, A, Emery, T, Robson, L, Pitkälä, K, Ilomäki, J & Bell, JS 2016, 'Analgesic use and pain in residents with and without dementia in aged care facilities: a cross-sectional study', Australasian Journal on Ageing, vol. 35, no. 3, pp. 180-187.

9 8 4
2016

Thai, L, Moss, J, Godman, B & Vitry, A 2016, 'Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme', Expert Review of Pharmacoeconomics and Outcomes Research: Informing Decision-Making in the Delivery of Cost-Effective Healthcare, vol. 16, no. 3, pp. 419-433.

Open access 1 1 1
2016

Thai, LP, Vitry, A I & Moss, JR 2016, 'Pricing and utilisation of proton pump inhibitors in South Australian public hospitals and the Pharmaceutical Benefits Scheme', Journal of Pharmacy Practice and Research, vol. 46, no. 2, pp. 130-136.

2 1
2016

Vitry, A, Mintzes, B & Lipworth, W 2016, 'Access to new cancer medicines in Australia: dispelling the myths and informing a public debate', Journal of Pharmaceutical Policy and Practice, vol. 9, no. 13, pp. 1-6.

Open access 5
2016

Vogler, S, Vitry, A I & Babar, Z-U-D 2016, 'Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study', Lancet Oncology, vol. 17, no. 1, pp. 39-47.

67 59 273
2015

Godman, B, Wilcock, M, Martin, A, Bryson, S, Vitry, AI & Malmström, RE and 33 other authors 2015, 'Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future', GaBI Journal, vol. 4, no. 3, pp. 125-135.

Open access
2015

Hillen, JB, Vitry, A & Caughey, G 2015, 'Evaluating medication-related quality of care in residential aged care: a systematic review', SpringerPlus, vol. 4, no. 220, pp. 1-17.

Open access 12 8
2015

Othman, N, Vitry, A I, Roughead, EE, Ismail, SB & Omar, K 2015, 'Doctors' views on the quality of claims provided by pharmaceutical representatives: a comparative study in Malaysia and Australia', Journal of Taibah University Medical Sciences, vol. 10, no. 4, pp. 471-480.

Open access 7
2015

Tan, ECK, Visvanathan, R, Hilmer, SN, Emery, T, Robson, L, Vitry, A, Hughes, JM, Jones, MJ, Moawad, S, Ilomaki, J, Quirke, T & Bell, JS 2015, 'Analgesic use and daytime sleepiness in residents with and without dementia in residential aged care facilities', Drugs and Aging, vol. 32, no. 12, pp. 1045-1053.

5 4
2015

Vitry, A, Nguyen, T, Entwistle, V & Roughead, E 2015, 'Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study', Journal of Pharmaceutical Policy and Practice, vol. 8, no. 25, pp. 1-11.

Open access 7 11
2014

Kelly, E, Lu, C, Albertini, S & Vitry, A 2014, 'Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison', Journal of Clinical Pharmacy and Therapeutics, vol. 40, no. 1, pp. 76-82.

8 7 2
2014

Tan, EC, Visvanathan, R, Hilmer, SN, Vitry, A I, Quirke, T, Emery, T, Robson, L, Shortt, T, Sheldrick, S, Lee, SW, Clothier, R, Reeve, E, Gnjidic, D, Ilomaki, J & Bell, JS 2014, 'Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol', BMJ Open, vol. 4, no. 6, article number e005757, pp. 1-6.

Open access 25 22 2
2014

Thai, LP, Vitry, A I & Moss, JR 2014, 'Discounting of medicines in Australian community pharmacies', Australian Health Review, vol. 38, no. 5, pp. 517-522.

2 1 6
2014

Vitry, A & Roughead, E 2014, 'Managed entry agreements for pharmaceuticals in Australia', Health Policy, vol. 117, no. 3, pp. 345-352.

21 25 7
2014

Vitry, AI, Nguyen, TA, Ramsay, EN, Caughey, GE, Gilbert, AL, Shakib, S, Ryan, P, Esterman, AJ, McDermott, RA & Roughead, EE 2014, 'General practitioner management plans delaying time to next potentially preventable hospitalization for patients with heart failure', Internal Medicine Journal, vol. 44, no. 11, pp. 1117-1123.

Open access 8 7 7
2013

Caughey, GE, Preiss, A, Vitry, AI, Gilbert, AL & Roughead, EE 2013, 'Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications', Diabetes Care, vol. 36, no. 10, pp. 3009-3014.

Open access 26 26 14
2013

Caughey, GE, Preiss, AK, Vitry, A I, Gilbert, AL, Ryan, P, Shakib, S, Esterman, A, McDermott, RA & Roughead, EE 2013, 'Does antidepressant medication use affect persistence with diabetes medicines?', Pharmacoepidemiology and Drug Safety, vol. 22, no. 6, pp. 615-622.

Open access 12 10 7
2013

Gabb, G, Vitry, A, Limaye, V & Alhami, G 2013, 'Serious statin-associated myotoxicity and rhabdomyolysis in Aboriginal and Torres Strait Islanders: a case series', Internal Medicine Journal, vol. 43, no. 9, pp. 987-992.

12 10
2013

Vitry, AI, Ng, HS & Vitre, P 2013, 'Assessment of the therapeutic value of new medicines marketed in Australia', Journal of Pharmaceutical Policy and Practice, vol. 6, article no. 2.

Open access 7 13
2012

Baumgärtel, C, Godman, B, Malmstrom, RE, Andersen, M, Vitry, AI & Gustafsson, LL and 22 other authors 2012, 'What lessons can be learned from the launch of generic clopidogrel?', GaBI Journal, vol. 1, no. 2, pp. 58-68.

Open access
2012

Vitry, A I & Mintzes, B 2012, 'Disease mongering and low testosterone in men: the tale of two regulatory failures', Medical Journal of Australia, vol. 196, no. 10, pp. 619-621.

13 11
2012

Vitry, A I, Roughead, EE, Ramsay, EN, Ryan, P, Caughey, GE, Esterman, A, Shakib, S, Gilbert, AL & McDermott, R 2012, 'Chronic disease management: does the disease affect likelihood of care planning?', Australian Health Review, vol. 36, no. 4, pp. 419-423.

5 5
2011

Caughey, GE, Roughead, EE, SHAKIB, S, Vitry, AI & Gilbert, AL 2011, 'Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data', Drugs and Aging, vol. 28, no. 7, pp. 575-581.

25 19
2011

Gilbert, AL, Caughey, GE, Vitry, AI, Clark, AB, Ryan, P, McDermott, RA, SHAKIB, S, Luszcz, M, Esterman, AJ & Roughead, EE 2011, 'Ageing well: improving the management of patients with multiple chronic health problems', Australasian Journal on Ageing, vol. 30, no. S2, pp. 32-37.

15 17 3
2011

Lu, CY, Barratt, J, Vitry, A & Roughead, E 2011, 'Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting', Journal of Clinical Epidemiology, vol. 64, no. 2, pp. 223-228.

39 38 3
2011

Roughead, EE, Vitry, A I, Caughey, GE & Gilbert, AL 2011, 'Multimorbidity, care complexity and prescribing for the elderly', Aging Health, vol. 7, no. 5, pp. 695-705.

13 1
2011

Vitry, A I, Roughead, EE, Ramsay, EN, Preiss, AK, Ryan, P, Gilbert, AL, Caughey, GE, Shakib, S, Esterman, A, Zhang, Y & McDermott, RA 2011, 'Major bleeding risk associated with warfarin and co-medications in the elderly population', Pharmacoepidemiology and Drug Safety, vol. 20, no. 10, pp. 1057-1063.

35 31
2011

Vitry, A, Thai, L & Lu, C 2011, 'Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia', Internal Medicine Journal, vol. 41, no. 2, pp. 162-166.

8 7
2011

Zhang, Y, Vitry, A, Caughey, G, Roughead, EE, Ryan, P, Gilbert, A, Shakib, S & McDermott, R 2011, 'The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes', Diabetes Research and Clinical Practice, vol. 91, no. 1, pp. 115-120.

3 2 3
2010

Caughey, GE, Ramsay, E, Vitry, AI, Gilbert, AL, Luszcz, M, Ryan, P & Roughead, EE 2010, 'Comorbid chronic diseases, discordant impact on mortality in the elderly; a 14 year longitudinal population study', Journal of Epidemiology and Community Health, vol. 64, no. 12, pp. 1036-1042.

Open access 35 29 6
2010

Caughey, GE, Roughead, EE, Pratt, N, Shakib, S, Vitry, A I & Gilbert, AL 2010, 'Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?', Pharmacoepidemiology and Drug Safety, vol. 19, no. 9, pp. 977-982.

30 27
2010

Caughey, GE, Roughead, EE, Shakib, S, McDermott, RA, Vitry, A I & Gilbert, AL 2010, 'Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants', Age and Ageing, vol. 39, no. 4, pp. 488-494.

Open access 38 33 6
2010

Caughey, GE, Roughead, EE, Vitry, AI, McDermott, RA, Shakib, S & Gilbert, AL 2010, 'Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts', Diabetes Research and Clinical Practice, vol. 87, no. 3, pp. 385-393.

95 81 3
2010

Othman, N, Vitry, A I, Roughead, EE, Ismail, SB & Omar, K 2010, 'Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia', BMC Public Health, vol. 10, article no. 743, pp.1-11.

Open access 22 15
2010

Othman, N, Vitry, AI & Roughead, EE 2010, 'Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study', Southern Med Review, vol. 3, no. 1, pp. 11-18.

6
2010

Othman, N, Vitry, AI & Roughead, EE 2010, 'Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States', BMC Public Health, vol. 10, article no. 294.

Open access 12 10
2010

Roughead, EE, Vitry, AI, Preiss, A, Barratt, JD, Gilbert, AL & Ryan, P 2010, 'Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease', European Journal of Preventative Cardiology, vol. 17, no. 1, pp. 71-76.

10 10
2010

Sorich, MJ, Vitry, AI, Ward, MB, Horowitz, J & McKinnon, RA 2010, 'Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data ', Journal of Thrombosis and Haemostasis, vol. 8, no. 8, pp. 1678-1684.

64 52 10
2010

Spurling, GK, Mansfield, P, Montgomery, BD, Lexchin, J, Doust, J, Othman, N & Vitry, AI 2010, 'Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review', PLoS Medicine, vol. 7, no. 10, article no. e1000352.

Open access 268 224 465
2010

Vitry, A I, Hoile, AP, Gilbert, AL, Esterman, A & Luszcz, MA 2010, 'The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people', Archives of Gerontology and Geriatrics, vol. 50, no. 3, pp. e1-4.

17 12
2010

Vitry, A I, Roughead, EE, Preiss, AK, Ryan, P, Ramsay, EN, Gilbert, AL, Caughey, GE, Shakib, S, Esterman, A, Zhang, Y & McDermott, RA 2010, 'Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study', PLoS One, vol. 5, no. 11, article no. e14024.

Open access 22 23
2010

Vitry, AI 2010, 'Reporting of Studies on New Medicines in Major Medical Journals: A Case Study in Breast Cancer', Clinical Pharmacology and Therapeutics, vol. 87, no. 4, pp. 398-400.

4 4
2010

Vitry, AI 2010, 'The imperative of happiness for women living with breast cancer', Canadian Woman Studies, vol. 28, no. 2-3, pp. 30-33.

2010

Zhang, Y, Chow, V, Vitry, A I, Ryan, P, Roughead, EE, Caughey, GE, Ramsay, EN, Gilbert, AL, Esterman, A & Luszcz, MA 2010, 'Antidepressant use and depressive symptomatology among older people from the Australian longitudinal study of ageing', International Psychogeriatrics, vol. 22, no. 3, pp. 437-444.

Open access 20 20 3
2010

Zhang, Y, Vitry, AI, Roughead, EE, Ryan, P & Gilbert, AL 2010, 'Co-morbidity and the utilization of health care for Australian veterans with diabetes', Diabetic Medicine, vol. 27, no. 1, pp. 65-71.

11 9
2009

Goh, LY, Vitry, A I, Semple, SJ, Esterman, A & Luszcz, MA 2009, 'Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population', BMC Complementary and Alternative Medicine, vol. 9, article no. 42.

Open access 74 61
2009

Othman, N, Vitry, AI & Roughead, EE 2009, 'Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review', PLoS One, vol. 4, no. 7, article no. e6350.

Open access 60 45
2009

Thomas, R & Vitry, A 2009, 'Consumers' perceptions of generic medicines in community pharmacies in Malaysia', Southern Med Review, vol. 2, no. 2, pp. 20-23.

2009

Vitry, A & Lai, Y 2009, 'Advertising of antihypertensive medicines and prescription sales in Australia', Internal Medicine Journal, vol. 39, no. 11, pp. 728-732.

6 6
2009

Vitry, A, Gilbert, A, Mott, K, Rao, D & March, G 2009, 'Provision of medicines information in Australian community pharmacies', International Journal of Clinical Pharmacy, vol. 31, no. 2, pp. 154-157.

5 4
2009

Vitry, AI 2009, 'Does Direct-to-Consumer Prescription Drug Advertising Do More Harm Than Good?', Annals of Internal Medicine, vol. 151, no. 11, pp. 823-824.

1 1
2009

Vitry, AI 2009, 'Written medicine information in Australia, answer to the letter to the editor.', International Journal of Clinical Pharmacy, vol. 31, no. 6, pp. 605-606.

1
2009

Vitry, AI, Bertele, V & Garattinii, S 2009, 'Drug Regulations and the need for Greater Transparence', The Regulatory Affairs Journal. Pharma, March, pp. 143-146.

2009

Vitry, AI, Wong, SA, Roughead, EE, Ramsay, E & Barratt, JD 2009, 'Validity of medication-based co-morbidity indices in the Australian elderly population', Australian and New Zealand Journal of Public Health, vol. 33, no. 2, pp. 126-130.

68 65
2008

Caughey, GE, Vitry, AI, Gilbert, AL & Roughead, EE 2008, 'Prevalence of comorbidity of chronic diseases in Australia', BMC Public Health, vol. 8, article no. 221.

Open access 133 111
2008

Roughead, EE, Gilbert, AL & Vitry, AI 2008, 'The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy', Health Policy, vol. 88, no. 2-3, pp. 250-257.

23 20
2008

Vitry, AI & Zhang, Y 2008, 'Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions', Medical Journal of Australia, vol. 189, no. 7, pp. 360-365.

Open access 67 29
2008

Vitry, AI 2008, 'Time for Transparency at teh TGA', Australian Prescriber.

2008

Vitry, AI 2008, 'Time for transparency at the TGA', Australian Prescriber.

2008

Vitry, AI, Lexchin, J, Sasich, L, Dupin-Spriet, T, Reed, T, Bertele, V, Garattinii, S, Toop, L & Hurley, E 2008, 'Provision of information on regulatory authorities' websites', Internal Medicine Journal, vol. 38, no. 7, pp. 559-567.

22 15
2008

Vitry, AI, Phillips, S & Semple, SJ 2008, 'Quality and availability of consumer information on heart failure in Australia', BMC Health Services Research, vol. 8, article no. 255.

Open access 6 4

Conferences

Year Output
2014

Hillen, J, Vitry, A & Caughey, G 2014, 'Epidemiology of disease, medication use and health service utilisation in Australian residential aged care. Implications for evaluating medication-related quality of care', 13th National Conference of Emerging Researchers in Ageing, Flinders University, pp. 76-83.

Reports

Year Output
2016

Vitry, A, Nguyen, T, Roughead, E, Baer, B, Bhushan, A & Tisocki, K 2016, Older people's access to medicines and assistive in the Western Pacific Region, World Health Organization, Western Pacific Region, Switzerland.

Open access
Close
  • close

Research

  • back
  • close

Current research & highlights

Quality use of medicines,Pharmaco-epidemiology,Medicines policies, pharmaceutical regulations, transparency of medicine agencies,Quality of medicines information for health professionals and consumers, clinical guidelines,Drug promotion, quality use of medicines, conflicts of interests,Assessment of new medicines
Close
  • Projects
  • Outputs
  • Current research & highlights
  • close

External engagement & recognition

Collaborations

  • close

External engagement & recognition

  • back
  • close

Collaborations

Organisation Country
Alzheimers Australia AUSTRALIA
Australian Medicines Handbook Pty Ltd AUSTRALIA
Austrian Health Institute AUSTRIA
Austrian Medicines and Medical Devices Agency AUSTRIA
Consumer Dementia Research Network AUSTRALIA
Deakin University AUSTRALIA
Flinders University AUSTRALIA
Harvard University UNITED STATES
Health Action International NETHERLANDS
International Islamic University Malaysia MALAYSIA
Karolinska Institute SWEDEN
Mario Negri Institute for Pharmacological Research ITALY
Ministry of Health, Republic of Indonesia INDONESIA
Monash University AUSTRALIA
National Institute of Clinical Studies AUSTRALIA
National University of Malaysia MALAYSIA
NHS Greater Glasgow and Clyde Board HQ UNITED KINGDOM
North West Commissioning Support Unit UNITED KINGDOM
Resthaven Incorporated AUSTRALIA
Resthaven Limited AUSTRALIA
Royal Adelaide Hospital AUSTRALIA
Royal Cornwall Hospitals NHS Trust UNITED KINGDOM
Shandong University CHINA
Taibah University SAUDI ARABIA
The University of Notre Dame Australia AUSTRALIA
Universiti Kabangsaan Malaysia MALAYSIA
University of Aberdeen UNITED KINGDOM
University of Adelaide AUSTRALIA
University of Auckland NEW ZEALAND
University of British Columbia CANADA
University of Helsinki FINLAND
University of Huddersfield UNITED KINGDOM
University of Lille 2 FRANCE
University of Liverpool UNITED KINGDOM
University of Otago NEW ZEALAND
University of Queensland AUSTRALIA
University of Science, Malaysia MALAYSIA
University of South Australia AUSTRALIA
University of Sydney AUSTRALIA
University of Western Australia AUSTRALIA
University of York UNITED KINGDOM
World Health Organisation SWITZERLAND
York University CANADA
Close
  • close

External engagement & recognition

  • back
  • close

External engagement & recognition

Engagement/recognition Year

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2017

Member

International Society for Pharmacoepidemiology (ISPE)

2017

Member

Health Technology Assessment International (HTAi)

2017

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2016

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2015

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2014

Best of the Best Poster Presentation Awards

Clinical Oncology Society of Australia

2013

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2013

Invited presentation

Flinders Centre for Innovation in Cancer Survivorship Conference

2013

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2012

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2011

Consultant / advisor, Cancer Australia Consumer Network

Cancer Australia, Australian Government

2010

Member, Program Reference Group (implementation and the evaluation of the $731m Fifth Community Agreement between the Commonwealth government and the Pharmacy Guild of Australia)

Australian Government

2010
Close
  • Collaborations
  • External engagement & recognition
  • close

Teaching & student supervision

  • close

Teaching & student supervision

  • back
  • close

Courses and programs

Courses I teach and/or co-ordinate

  • PHAR 4019 Issues in Contemporary Pharmacy Practice (2020)
  • PHAR 4019 Issues in Contemporary Pharmacy Practice (2019)
  • PHAR 4019 Issues in Contemporary Pharmacy Practice (2018)
  • HLTH 1025 Health and Society (2020)
  • HLTH 1025 Health and Society (2019)
  • HLTH 1025 Health and Society (2018)
Close
  • close

Teaching & student supervision

  • back
  • close

Research degree supervision

Supervisions from 2010 shown

Thesis title Student status
Role of Circular RNAs in Glioblastoma Current
Assessment of the burden, types and development of comorbidities in the Australian population with cancer Completed
Indicators for evaluating medication-related quality of care in Australian residential aged care Completed
Quality of information in pharmaceutical promotion Completed
The impact of pricing policies on Australia's medicines market Completed
Close
  • Courses and programs
  • Research degree supervision
  • close

About me

  • back
  • close

Gallery

Close
more less

Contact us

  • Enquire online

International Students

  • +618 8302 0114
  • Further contact details

Australian Students

  • 08 8302 2376

General Enquiries

  • 08 8302 6611
  • Further contact details

Links & legal

  • CRICOS Provider no 00121B
  • Web accessibility
  • Disclaimers
  • Privacy Statement
  • Copyright 2014
  • Connect with UniSA
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

Aboriginal art imageUniSA respects the Kaurna, Boandik and Barngarla peoples’ spiritual relationship with their country.

SA

Australian Technology Network